You all miss the point
Starpharma is going to own 22.5% of a company that will develop a drug using Starpharma's DEP platform. There is no risk to us and only upside.
Starpharma will be leveraging it's technology platform multiple times to many entities. It will be rewarded in several different ways
Whether it is equity exit model as in the deal with Medicxi
Whether it is the collaborations with other big pharmas model, turning into clinical trials with licensing deals and milestones and royalties.
Whether it is in in-house development to POC model spending millions of dollars and then selling or licensing out as with DEP CDA (Cabazitaxel, Docetaxel, Irinotecan)
Our technology platform can be compared t0 changing channels with remote control on TV using free to air and streaming. Point and Play
To coin a phrase
So much optionality
I look forward to future announcement
- Forums
- ASX - By Stock
- Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
You all miss the point Starpharma is going to own 22.5% of a...
-
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 372123 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 5042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 372123 | 0.099 |
2 | 140000 | 0.098 |
1 | 64565 | 0.097 |
1 | 50000 | 0.095 |
3 | 41738 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 5042 | 1 |
0.105 | 137318 | 2 |
0.110 | 226808 | 10 |
0.115 | 122327 | 4 |
0.120 | 139405 | 10 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |